DS11 Buffering of lidocaine, time for a British Society for Dermatological Surgery position statement?

Uyen Nguyen,Katrina Habaluyas,Thomas Oliphant
DOI: https://doi.org/10.1093/bjd/ljae090.206
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract Patients often experience pain or discomfort during local anaesthetic administration in Mohs surgery. Buffering local anaesthetics with sodium bicarbonate has been proven as a potential means to mitigate this pain in various research. However, despite the evidence, there are no standardized guidelines in the UK outlining the application of sodium bicarbonate buffering, which results in its limited application in practice and potential to improve patient comfort and quality of healthcare. This study investigates the usage of sodium bicarbonate-buffered Xylocaine solution in Mohs micrographic surgery as a simple, effective technique to reduce discomfort associated with the injection of local anaesthetic at a tertiary centre in the UK. Sodium bicarbonate (2 mL of 8.4% w/v) was mixed with 20 mL of Xylocaine 1% (lidocaine 1% with adrenaline 1 : 200 000) in a ratio of 1 : 10 to create a buffered solution. This buffered mixture was used for anaesthesia during Mohs surgery procedures on the head and neck. Pain assessment was conducted using a numerical rating scale ranging from 0 to 10, with 10 representing the worst pain. Pain scores were collected for each lesion injected in all patients receiving unbuffered Xylocaine and buffered Xylocaine. Unpaired t-tests were used for statistical analysis to compare the average pain score per lesion in both groups. The study included 62 patients, 28 receiving unbuffered Xylocaine and 34 receiving buffered Xylocaine. In total, 37 lesions were injected with buffered Xylocaine, and 47 lesions were injected with unbuffered Xylocaine. The average pain score for each lesion in the buffered Xylocaine group was lower than for the unbuffered Xylocaine group: 0.94 and 1.76, respectively (P = 0.03). For patients receiving injections to the nose (n = 16), 11 received buffered Xylocaine for 12 nose lesions, and five received unbuffered Xylocaine group for six nose lesions. The average pain score per nose lesion in the buffered Xylocaine group (0.75) was notably lower than that in the plain Xylocaine group (3.8) (P = 0.002). Additionally, 17 patients were surveyed regarding their previous experiences with unbuffered Xylocaine injections at the same anatomical location. Out of these, 16 patients reported that buffered Xylocaine injections were less painful, while only one patient perceived no difference in pain. No adverse effects related to sodium bicarbonate were reported. The study demonstrates that buffering Xylocaine 1% with sodium bicarbonate 8.4% is a simple and effective technique to reduce discomfort associated with the injection of local anaesthetic among patients undergoing Mohs micrographic surgery, potentially improving overall patient satisfaction. This highlights the need for comprehensive guidelines to guide its integration into practice with the goal of optimizing patient care.
dermatology
What problem does this paper attempt to address?